Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (141-150 of 284) with videos related to

Pageof 29
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignanciesM H Gaspard, D Maraninchi, A M Stoppa, et al.
Revue D'Epidemiologie Et De Sante Publique|April 1, 1996
[Comparative study of the costs for two hematopoietic cell specimen collections: cytapheresis and bone marrow collection]A G Le Corroller, G Macquart-Moulin, P Auquier, et al.
Bone Marrow Transplantation|January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remissionD Blaise, M H Gaspard, A M Stoppa, et al.
Bulletin Du Cancer|July 1, 1995
[Comparison of anxiety and pain in two procedures of hematopoietic stem cell collection: cytapheresis and bone marrow collection]G Macquart-Moulin, P Auquier, A G Le Corroller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow TransplantationJ W Sweetenham, S J Proctor, D Blaise, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|April 3, 2001
Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantationH Tayebi, P Tiberghien, C Ferrand, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Bone Marrow Transplantation|March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
Pageof 29

Showing results (141-150 of 284) with videos related to

Sort By:
Pageof 29
Cancer Chemotherapy and Pharmacology|January 1, 1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignanciesM H Gaspard, D Maraninchi, A M Stoppa, et al.
Revue D'Epidemiologie Et De Sante Publique|April 1, 1996
[Comparative study of the costs for two hematopoietic cell specimen collections: cytapheresis and bone marrow collection]A G Le Corroller, G Macquart-Moulin, P Auquier, et al.
Bone Marrow Transplantation|January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remissionD Blaise, M H Gaspard, A M Stoppa, et al.
Bulletin Du Cancer|July 1, 1995
[Comparison of anxiety and pain in two procedures of hematopoietic stem cell collection: cytapheresis and bone marrow collection]G Macquart-Moulin, P Auquier, A G Le Corroller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow TransplantationJ W Sweetenham, S J Proctor, D Blaise, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|April 3, 2001
Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantationH Tayebi, P Tiberghien, C Ferrand, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Bone Marrow Transplantation|March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not availableS Garciaz, L Castagna, R Bouabdallah, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
Pageof 29